Tocagen Inc (TOCA) Stake Lessened by Nicholas Investment Partners LP

Nicholas Investment Partners LP lowered its position in shares of Tocagen Inc (NASDAQ:TOCA) by 50.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,000 shares of the company’s stock after selling 50,000 shares during the period. Nicholas Investment Partners LP owned approximately 0.25% of Tocagen worth $623,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. New York State Common Retirement Fund acquired a new stake in shares of Tocagen during the 2nd quarter worth approximately $108,000. TD Asset Management Inc. acquired a new stake in shares of Tocagen during the 2nd quarter worth approximately $158,000. Schwab Charles Investment Management Inc. acquired a new stake in shares of Tocagen during the 2nd quarter worth approximately $165,000. California State Teachers Retirement System acquired a new stake in shares of Tocagen during the 2nd quarter worth approximately $179,000. Finally, Teachers Advisors LLC acquired a new stake in shares of Tocagen during the 2nd quarter worth approximately $181,000. Institutional investors and hedge funds own 36.22% of the company’s stock.

Tocagen Inc (NASDAQ:TOCA) opened at $10.69 on Thursday. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.07. Tocagen Inc has a 1 year low of $8.60 and a 1 year high of $17.95.

Tocagen (NASDAQ:TOCA) last posted its quarterly earnings data on Wednesday, November 8th. The company reported ($0.50) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.48) by ($0.02). The company had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $0.01 million. equities analysts expect that Tocagen Inc will post -2.88 earnings per share for the current fiscal year.

Separately, Zacks Investment Research upgraded shares of Tocagen from a “sell” rating to a “hold” rating in a report on Thursday, September 21st.

COPYRIGHT VIOLATION WARNING: “Tocagen Inc (TOCA) Stake Lessened by Nicholas Investment Partners LP” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3079221/tocagen-inc-toca-stake-lessened-by-nicholas-investment-partners-lp.html.

About Tocagen

Tocagen Inc (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells.

Institutional Ownership by Quarter for Tocagen (NASDAQ:TOCA)

Receive News & Ratings for Tocagen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tocagen Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.